Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 24, 2017

DrugPatentWatch Database Preview

Ursodiol - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for ursodiol and what is the scope of ursodiol freedom to operate?

Ursodiol
is the generic ingredient in four branded drugs marketed by Glenmark Generics, Epic Pharma, Impax Labs Inc, Mylan, Par Pharm, Forest Labs Inc, Lannett, Teva Pharms Usa, Teva Pharms, and Allergan Sales Llc, and is included in eleven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are five drug master file entries for ursodiol. Twenty-eight suppliers are listed for this compound.

Summary for Generic Name: ursodiol

Tradenames:4
Patents:1
Applicants:10
NDAs:11
Drug Master File Entries: see list5
Suppliers / Packagers: see list28
Bulk Api Vendors: see list47
Clinical Trials: see list8
Patent Applications: see list5,050
Therapeutic Class:Gastrointestinal Agents
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:ursodiol at DailyMed

Pharmacology for Ingredient: ursodiol

Ingredient-typeBile Acids and Salts
Drug ClassBile Acid
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Par Pharm
URSODIOL
ursodiol
TABLET;ORAL202540-002Feb 14, 2013ABRXNoNo► Subscribe► Subscribe
Mylan
URSODIOL
ursodiol
CAPSULE;ORAL090530-001Feb 17, 2010ABRXNoNo► Subscribe► Subscribe
Lannett
URSODIOL
ursodiol
CAPSULE;ORAL079082-001Dec 15, 2008ABRXNoNo► Subscribe► Subscribe
Teva Pharms
URSODIOL
ursodiol
CAPSULE;ORAL075592-001May 25, 2000ABRXNoNo► Subscribe► Subscribe
Impax Labs Inc
URSODIOL
ursodiol
CAPSULE;ORAL077895-001Jul 27, 2006BXRXNoNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Predict branded drug patent expiration
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot